DSD Pharma is a GDP-certified distributor of pharmaceuticals, radiopharmaceuticals and medical products, and medical-technical equipment in the field of nuclear medicine and radiopharmacy.
In nuclear medicine diagnostics, patients are administered radioactive drugs, so-called radiopharmaceuticals. Depending on their pharmacological properties, these accumulate in varying concentrations in the organs or tissues of the person. The radiopharmaceutical then emits a weak radiation that can be detected in PET-CT, SPECT-CT or scintigraphy, depending on the type of examination.
In diagnostics, DSD Pharma offers a range of radiopharmaceuticals, peptides and labelling kits for the fields of scintigraphy, positron emission tomography (PET) and single photon emission computed tomography (SPECT).
DSD Pharma is a competent partner in all matters relating to diagnostics, therapy and theranostics in nuclear medicine: DSD Pharma’s innovative and broad product portfolio includes holistic and customised solutions for specific requirements – from the provision of radioactive substances to the handling of logistics and transport to the set-up of hot rooms.
DSD Pharma works with national and international suppliers and manufacturers who enable us to ensure the diversity and variety of our product portfolio. In addition to diagnostics, DSD Pharma also offers therapeutics, medical devices, medical-technical equipment, synthesis modules for the production of radiopharmaceuticals, equipment for radiopharmacy and hot rooms, nuclide databases, contained sources and much more.